Microbial therapeutics and opportunities in HIV - Ma Somsouk

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Development of a live biotherapeutic product: Opportunities and challenges - Scott Plevy, MD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Ontwikkelingen nieuwe ARV en PrEP in 2019 - Kees Brinkman

Ontwikkelingen op het gebied van HIV Cure - Annemarie Wensing

Ontwikkelingen HIV resistentie en eliminatie - Charles Boucher

Farmacologie bij CROI 2019: focus op zwangerschap en pediatrie - David Burger

HIV: een gewichtige ziekte - Andy Hoepelman

Global Challenges in Hepatitis B Treatment - Iván Antúnez-González, MD

Starting HAART in 2019: When and How - Pedro Cahn, MD, PhD

The Puerto Rican Experience: Discussion - Vivian Tamayo

Challenges with the Implementation of PrEP - Kenneth Mayer, MD

PEP After Sexual Exposures - Mauro Schechter, MD, PhD

New ARVs/New Strategies - Pablo Tebas, MD

Local Situation in Puerto Rico: Epidemiology and Treatment Options - Jorge Santana, MD

DDA's Paradigm in HCV Treatment - David Kershenobich Stalnikowitz, MD, Phd

Hurricane Maria’s Viral Impact: HIV Care Outcomes Among Substance Users in Puerto Rico Following Hurricane Maria - Hernández

HCV Treatment in Renal Impaired Patients - David Roth, MD, PhD

The Role of The National HIV Behavioral Surveillance System in Puerto Rico - Rolón Colón

Associations Between Hepatitis C and Social Determinants of Health in a Sample of Injecting Drug Users Living with HIV in Puerto Rico - Maisonet Alejandro

Problematic Use of Drugs and HIV and Hepatitis Risks in Puerto Rico - Camila Gelpi-Acosta, PhD

Treatment and Care with Vulnerable Populations - Amanda Castel, MD, MPH

Clinical Case Presentation(s) - Carlos Rodríguez-Díaz, PhD

Prevention and care strategies for the high risk population in Puerto Rico - Carlos Rodríguez-Díaz, PhD

The Struggles of the Aging (Co-infected) Population - Iván Meléndez-Rivera, MD, FAAFP